Anis Askarizadeh

Statistics

Publications

Citations

214

H-Index

Active since

2022

Affiliations

Mashhad University of Medical Sciences(Current)

Biotechnology Research Center

University of Manchester

Ahvaz Jundishapur University of Medical Sciences

Anis Askarizadeh is an author at Mashhad University of Medical Sciences specializing in liposomal formulations, liposome-based delivery, and oncology.

ORCID

Publications per year

2022–2024

Publications

Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy

Anis Askarizadeh, Mohammad Mashreghi, Elaheh Mirhadi et al. · Cancer Nanotechnology · 2023 · 54 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy

Elaheh Mirhadi, Mohammad Mashreghi, Anis Askarizadeh et al. · Scientific Reports · 2022 · 48 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity

Saba Dadpour, Amin Mehrabian, Mahdieh Arabsalmani et al. · IET Nanobiotechnology · 2022 · 29 citations · Full text

Pharmacy, Oncology, Pharmacology +17

The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice

Amin Mehrabian, Saba Dadpour, Mohammad Mashreghi et al. · IET Nanobiotechnology · 2023 · 18 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Amino acid coordination complex mediates cisplatin entrapment within PEGylated liposome: An implication in colorectal cancer therapy

Elaheh Mirhadi, Fatemeh Gheybi, Nadya Mahmoudi et al. · International Journal of Pharmaceutics · 2022 · 15 citations

Medicine, Molecular Pharmaceutics, Oncology +14

1–5 of 9